HCA Healthcare Inc (HCA) Position Lessened by M&T Bank Corp

M&T Bank Corp trimmed its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 3.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,839 shares of the company’s stock after selling 792 shares during the quarter. M&T Bank Corp’s holdings in HCA Healthcare were worth $3,090,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of HCA. Benjamin F. Edwards & Company Inc. purchased a new position in shares of HCA Healthcare in the 4th quarter valued at about $25,000. Moody National Bank Trust Division purchased a new position in shares of HCA Healthcare in the 4th quarter valued at about $27,000. Trust Co. of Vermont boosted its stake in shares of HCA Healthcare by 165.3% in the 4th quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock valued at $41,000 after buying an additional 205 shares during the period. Csenge Advisory Group purchased a new position in shares of HCA Healthcare in the 3rd quarter valued at about $48,000. Finally, Private Capital Group LLC boosted its stake in shares of HCA Healthcare by 346.0% in the 4th quarter. Private Capital Group LLC now owns 446 shares of the company’s stock valued at $56,000 after buying an additional 346 shares during the period. 72.85% of the stock is owned by hedge funds and other institutional investors.

HCA opened at $139.53 on Monday. The firm has a market cap of $48.02 billion, a price-to-earnings ratio of 14.28, a PEG ratio of 1.16 and a beta of 0.80. HCA Healthcare Inc has a one year low of $93.03 and a one year high of $147.42.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 29th. The company reported $2.99 EPS for the quarter, topping the Zacks’ consensus estimate of $2.59 by $0.40. The company had revenue of $12.27 billion for the quarter, compared to the consensus estimate of $12.10 billion. HCA Healthcare had a negative return on equity of 91.25% and a net margin of 8.11%. HCA Healthcare’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the business earned $2.12 earnings per share. As a group, equities analysts predict that HCA Healthcare Inc will post 10.02 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 1st will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.15%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.35. The ex-dividend date of this dividend is Thursday, February 28th. HCA Healthcare’s payout ratio is presently 14.33%.

In other HCA Healthcare news, SVP Deborah M. Reiner sold 466 shares of the business’s stock in a transaction on Tuesday, February 5th. The stock was sold at an average price of $139.07, for a total transaction of $64,806.62. Following the sale, the senior vice president now directly owns 5,037 shares in the company, valued at $700,495.59. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 820 shares of the business’s stock in a transaction on Tuesday, November 13th. The stock was sold at an average price of $142.36, for a total value of $116,735.20. Following the sale, the senior vice president now owns 4,237 shares in the company, valued at $603,179.32. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,809 shares of company stock worth $254,181. 2.80% of the stock is owned by company insiders.

HCA has been the subject of several recent analyst reports. Zacks Investment Research upgraded HCA Healthcare from a “hold” rating to a “buy” rating and set a $157.00 target price for the company in a research note on Monday, November 19th. Deutsche Bank initiated coverage on HCA Healthcare in a research note on Thursday, January 3rd. They set a “buy” rating and a $140.00 target price for the company. Oppenheimer boosted their target price on HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 30th. UBS Group initiated coverage on HCA Healthcare in a research note on Thursday, November 15th. They set a “buy” rating and a $162.00 target price for the company. Finally, Jefferies Financial Group boosted their target price on HCA Healthcare from $155.00 to $158.00 and gave the stock a “buy” rating in a research note on Wednesday, October 31st. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and eighteen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $148.43.

ILLEGAL ACTIVITY WARNING: This story was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another domain, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this story can be accessed at https://www.com-unik.info/2019/02/11/hca-healthcare-inc-hca-position-lessened-by-mt-bank-corp.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: How does inflation affect different investments?

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit